Zdrowie i gospodarka · 24/08/2017

FDA Releases Draft Guidance for Industry on Identifying Trading Partners Under the Drug Supply Chain Security Act

The Food and Drug Administration (FDA) has published a draft guidance to help industry and state and local governments understand how to categorize entities in the drug supply chain under the Drug Supply Chain Security Act (DSCSA), and is seeking public input on private-label distributors